ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

VYGR Voyager Therapeutics Inc

8.47
0.65 (8.31%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 614,454
Bid Price 8.42
Ask Price 8.50
News -
Day High 8.56

Low
6.06

52 Week Range

High
14.3398

Day Low 7.80
Share Name Share Symbol Market Stock Type
Voyager Therapeutics Inc VYGR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.65 8.31% 8.47 18:22:58
Open Price Low Price High Price Close Price Previous Close
7.80 7.80 8.56 8.36 7.82
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
7,872 614,454 US$ 8.15 US$ 5,008,932 - 6.06 - 14.3398
Last Trade Type Quantity Price Currency
18:59:16 13 US$ 8.50 USD

Voyager Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
453.41M 54.30M - 250.01M 132.33M 2.44 3.43
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Voyager Therapeutics News

Date Time Source News Article
4/22/202415:30GlobeNewswire Inc.Voyager Therapeutics to Present Broad Set of Translational..
4/16/202406:00GlobeNewswire Inc.Voyager Therapeutics Announces Selection of Development..
3/26/202415:01GlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under..
3/13/202406:00GlobeNewswire Inc.Voyager Therapeutics Announces Appointment of Toby Ferguson..
2/28/202415:01GlobeNewswire Inc.Voyager Therapeutics Reports Fourth Quarter and Full Year..
2/28/202415:00Edgar (US Regulatory)Form 8-K - Current report
2/26/202406:00GlobeNewswire Inc.Voyager Therapeutics Announces Selection of Gene Therapy..
2/22/202415:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/21/202414:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/21/202414:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/21/202406:00GlobeNewswire Inc.Voyager Therapeutics Announces Fourth Quarter 2023..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VYGR Message Board. Create One! See More Posts on VYGR Message Board See More Message Board Posts

Historical VYGR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.658.567.267.64446,1150.8210.72%
1 Month9.639.727.268.22504,183-1.16-12.05%
3 Months7.4010.667.088.86669,3441.0714.46%
6 Months6.5811.726.068.72653,7211.8928.72%
1 Year7.2014.33986.069.46557,6731.2717.64%
3 Years4.8914.33982.465.74882,7123.5873.21%
5 Years21.1228.792.467.32680,828-12.65-59.90%

Voyager Therapeutics Description

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. The company operates in a single segment of developing and commercializing gene therapies.

Your Recent History

Delayed Upgrade Clock